Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Hereditary Testing Market, Disease Type
7.1. Hereditary Testing Market, Disease Type, 2020-2030
7.1.1. Hereditary Cancer Testing
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Hereditary Non-cancer Testing
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Hereditary Testing Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.2. Europe
8.2.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.3. APAC
8.3.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.4. MEA
8.4.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.5. Latin America
8.5.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, Disease Type (2016-2030)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, Disease Type (2016-2030)
Chapter 9. Company Profiles
9.1. Myriad Genetics, Inc.
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Invitae Corporation
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Illumina, Inc.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Natera, Inc.
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Laboratory Corporation of America Holdings
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. F. Hoffmann-La Roche Ltd
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Quest Diagnostics Incorporated.
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. CooperSurgical, Inc.
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Agilent Technologies, Inc.
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
Glossary of Terms